Our Research and Innovation
At CMH Research and Innovation, we are committed to pushing the boundaries of healthcare.
NGS - Next Generation Sequencing
Our next-generation sequencing tests are designed to provide accurate and detailed information about a patient's genetic makeup. This technology allows us to identify genetic mutations and variations that may contribute to the development of certain diseases.
MicroArray
Our MicroArray tests are used to detect genetic abnormalities that may cause developmental delays, intellectual disabilities, and birth defects. This technology allows us to diagnose conditions at an early stage, which can lead to more effective treatment options.
Molecular and Chromosomal Testing
Our Molecular and Chromosomal tests are used to detect genetic mutations that may cause certain types of cancer. These tests allow us to personalize treatment options and improve patient outcomes.
Molecular Cyto (FISH)
Our Molecular Cyto (FISH) tests are designed to identify genetic mutations that may cause certain types of leukemia and lymphoma. This technology allows us to diagnose conditions at an early stage and develop personalized treatment plans for our patients.